Easy to use.
Everywhere and at any time.
Have the cancer risk of moles assessed anywhere, anytime quickly, easily and accurately with SkinScreener.
1. take a photo of your skin
Once you download the app, you can take a photo of your skin using your phone’s camera. The app prompts you to take photos of moles, freckles, or other skin spots that you are concerned about.
2. get an analysis
After you take the photos, the app uses artificial intelligence to analyze them and determine if any of the spots are a cause for concern. The analysis takes into account factors such as size, color and shape.
3. you receive a risk assessment
Based on the analysis, the app gives a risk rating for each photographed spot. This assessment will tell you if the spot is low, medium or high risk and if you should see a dermatologist for further evaluation.
4. body map
The filter is designed to identify the different types of moles and spots that can appear on different parts of the body, and it can be used by both individuals and medical professionals. It provides an easy and convenient way to monitor and track moles and spots on specific areas of the body.
5. archives
The archive stores all scanned moles and allows users to get information about on which part of the body the mole appears and what risk is associated with it. This filtering feature is helpful for individuals with an increased risk of skin cancer or a history of skin cancer to monitor their skin health.
It is now more important than ever
Protect your skin
Choose a plan and get in in minutes. Before registration you will get a free scan.
We have the answers to your questions
A detailed collection of frequently asked questions about the app, features, costs and privacy issues can be found here.
According to the Medical Device Directive 93/42/EEC, a ‘medical device’ means any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of:
- diagnosis, prevention, monitoring, treatment or alleviation of disease,
- diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap,
investigation, replacement or modification of the anatomy or of a physiological process, - control of conception,
and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.
Yes, the protection of personal data with respect to data processing is important to medaia GmbH as the data controller. Consequently, when using personal data, medaia GmbH complies with all the provisions of the General Data Protection Regulation (GDPR) and the Data Protection Act (DSG) and strives for the best possible transparency. medaia GmbH processes personal data in accordance with the principles of lawfulness, good faith, transparency, accuracy, purpose limitation, data minimization, and storage limitation.
SkinScreener’s risk assessment is based on a clinically validated algorithm developed and tested in collaboration with the Medical University of Graz. The algorithm works with a neural network that uses artificial intelligence to ensure a risk assessment with 95% accuracy.
Easy to use.
Everywhere and at any time.
Have the cancer risk of moles assessed quickly, easily and accurately anywhere, anytime with SkinScreener.
*Apple App Store available in a few days!
- SkinScreener cannot replace a dermatological examination. SkinScreener does not diagnose and is not a substitute for regular visits to dermatologists.
